Identification of VAR2CSA domain-specific inhibitory antibodies of the plasmodium falciparum erythrocyte membrane protein 1 using a novel flow cytometry assay

Clinical and Vaccine Immunology

Volumn 20, Issue 3, 2013, Pages 433-442

  Obiakor, Harold ^a   Avril, Marion ^a   MacDonald, Nicholas J ^c   Srinivasan, Prakash ^a   Reiter, Karine ^a   Anderson, Charles ^a   Holmes, Kevin L ^b   Fried, Michal ^a   Duffy, Patrick E ^a   Smith, Joseph D ^a   Narum, David L ^a   Miller, Louis H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN 4 SULFATE; DUFFY BINDING PROTEIN; ERYTHROCYTE MEMBRANE PROTEIN 1; IMMUNOGLOBULIN G; PROTEIN DBL2X; PROTEIN DBL2X S3; PROTEIN DBL2X S3 ANTIBODY; PROTEIN DBL3X; PROTEIN DBL3X S3; PROTEIN VAR2CSA; PROTEOCHONDROITIN SULFATE; RECOMBINANT ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; CELL CLONE; CHO CELL; CONTROLLED STUDY; ENDEMIC DISEASE; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; FLOW CYTOMETRY INHIBITION OF BINDING ASSAY; HETEROLOGOUS EXPRESSION; IMMUNIZATION; MALARIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PREGNANT WOMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PURIFICATION; PROTEIN REFOLDING; PROTEIN SYNTHESIS; RAT; RELIABILITY; REPRODUCIBILITY; SURFACE PLASMON RESONANCE; TANZANIA;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHO CELLS; CHONDROITIN SULFATE PROTEOGLYCANS; CLONING, MOLECULAR; CRICETINAE; CRICETULUS; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; PLASMODIUM FALCIPARUM; PREGNANCY; PROTEIN BINDING; RABBITS; RATS; RECOMBINANT PROTEINS; SURFACE PLASMON RESONANCE; TANZANIA;

EID: 84875035670     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00638-12     Document Type: Article

References (43)

1. Baruch DI, Pasloske BL, Singh HB, Bi X, Ma XC, Feldman M. 1995. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82:77-87.
2. Smith JD, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE, Peterson DS. 1995. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82:101-110.
3. Su XZ, Heatwole VM, Wertheimer SP, Guinet F, Herrfeldt JA, Peterson DS. 1995. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparuminfected erythrocytes. Cell 82:89-100.
4. Costa FT, Avril M, Nogueira PA, Gysin J. 2006. Cytoadhesion of Plasmodium falciparum-infected erythrocytes and the infected placenta: a two-way pathway. Braz. J. Med. Biol. Res. 39:1525-1536.
5. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO. 2010. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 7:e1000221. doi:10.1371/journal.pmed .1000221.
6. Ouattara A, Mu J, Takala-Harrison S, Saye R, Sagara I, Dicko A, Niangaly A, Duan J, Ellis RD, Miller LH, Su XZ, Plowe CV, Doumbo OK. 2010. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. Malar. J. 9:175. doi:10.1186/1475-2875-9-175
7. Duffy PE, Fried M. 2003. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect. Immun. 71:6620-6623.
8. Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. 1998. Maternal antibodies block malaria. Nature 395:851-852.
9. Salanti A, Dahlback M, Turner L, Nielsen MA, Barfod L, Magistrado P, Jensen ATR, Lavstsen T, Ofori MF, Marsh K, Hviid L, Theander TG. 2004. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J. Exp. Med. 200:1197-1203.
10. Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L. 2004. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 363:283-289.
11. Duffy MF, Maier AG, Byrne TJ, Marty AJ, Elliott SR, O'Neill MT, Payne PD, Rogerson SJ, Cowman AF, Crabb BS, Brown GV. 2006. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 148: 117-124.
12. Gamain B, Trimnell AR, Scheidig C, Schert A, Miller LH, Smith JD. 2005. Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. J. Infect. Dis. 191:1010-1013.
13. Salanti A, Staalsoe T, Lavstsen T, Jensen AT, Sowa MP, Arnot DE, Hviid L, Theander TG. 2003. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol. Microbiol. 49: 179-191.
14. Tuikue Ndam N, Deloron P. 2008. Towards a vaccine against pregnancyassociated malaria. Parasite 15:515-521.
15. Viebig NK, Gamain B, Scheidig C, Lépolard C, Przyborski J, Lanzer M, Gysin J, Scherf A. 2005. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep. 6:775-781. 16. Kraemer SM, Smith JD. 2006. A family affair: var genes, PfEMP1 binding, and malaria disease. Curr. Opin. Microbiol. 9:374-380.
16. Viebig NK, Levin E, Dechavanne S, Rogerson SJ, Gysin J, Smith JD, Scherf A, Gamain B. 2007. Disruption of Var2csa gene impairs placental malaria associated adhesion phenotype. PLoS One 2:e910. doi:10.1371/journal.pone. 0000910.
17. Andersen P, Nielsen MA, Resende M, Rask TS, Dahlback M, Theander T, Lund O, Salanti A. 2008. Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA. PLoS Pathog. 4:e42. doi:10 .1371/journal.ppat.0040042.
18. Khunrae P, Dahlbäck M, Nielsen MA, Andersen G, Ditlev SB, Resende M, Pinto VV, Theander TG, Higgins MK, Salanti A. 2010. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies. J. Mol. Biol. 397:826-834.
19. Srivastava A, Gangnard S, Round A, Dechavanne S, Juillerat A, Raynal B, Faure G, Baron B, Ramboarina S, Singh SK, Belrhali H, England P, Lewit-Bentley A, Scherf A, Bentley GA, Gamain B. 2010. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc. Natl. Acad. Sci. U. S. A. 107: 4884-4889.
20. Boeuf P, Hasang W, Hanssen E, Glazier JD, Rogerson SJ. 2011. Relevant assay to study the adhesion of Plasmodium falciparum-infected erythrocytes to the placental epithelium. PLoS One 6:e21126. doi:10.1371/journal .pone.0021126.
21. Srivastava A, Gangnard S, Dechavanne S, Amirat F, Lewit Bentley A, Bentley GA, Gamain B. 2011. Var2CSA minimal CSA binding region is located within the N-terminal region. PLoS One 6:e20270. doi:10.1371/journal.pone.0020270.
22. Clausen TM, Christoffersen S, Dahlback M, Langkilde AE, Jensen KE, Resende M, Agerbaek MO, Andersen D, Berisha B, Ditlev SB, Pinto VV, Nielsen MA, Theander TG, Larsen S, Salanti A. 2012. Structural and functional insight into how the Plasmodium falciparum VAR2CSA pro-tein mediates binding to chondroitin sulfate A in placental malaria. J. Biol. Chem. 287:23332-23345.
23. Higgins MK. 2008. The structure of a chondroitin sulfate-binding domain important in placental malaria. J. Biol. Chem. 283:21842-21846.
24. Singh K, Gittis AG, Nguyen P, Gowda DC, Miller LH, Garboczi DN. 2008. Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A. Nat. Struct. Mol. Biol. 15:932-938.
25. Sharling L, Enevold A, Sowa KM, Staalsoe T, Arnot DE. 2004. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A. Malar J. 3:31. doi:10.1186/1475-2875-3-31.
26. Avril M, Hathaway MJ, Srivastava A, Dechavanne S, Hommel M, Beeson JG, Smith JD, Gamain B. 2011. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not crossinhibit different placental-type parasite isolates. PLoS One 6:e16622. doi: 10.1371/journal.pone.0016622.
27. Avril M, Cartwright MM, Hathaway MJ, Hommel M, Elliott SR, Williamson K, Narum DL, Duffy PE, Fried M, Beeson JG, Smith JD. 2010. Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes. Infect. Immun. 78:2248-2256.
28. Avril M, Kulasekara BR, Gosse SO, Rowe C, Dahlback M, Duffy PE, Fried M, Salanti A, Misher L, Narum DL, Smith JD. 2008. Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancyassociated malaria vaccine candidate VAR2CSA. Infect. Immun. 76:1791-1800.
29. Fernandez P, Petres S, Mecheri S, Gysin J, Scherf A. 2010. Straintranscendent immune response to recombinant Var2CSA DBL5-e domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions. PLoS One 5:e12558. doi:10.1371/journal.pone.0012558.
30. Nielsen MA, Pinto VV, Resende M, Dahlbäck M, Ditlev SB, Theander TG, Salanti A. 2009. Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA. Infect. Immun. 77:2482-2487.
31. Oleinikov AV, Francis SE, Dorfman JR, Rossnagle E, Balcaitis S, Getz T, Avril M, Gose S, Smith JD, Fried M, Duffy PE. 2008. VAR2CSA domains expressed in Escherichia coli induce cross-reactive antibodies to native protein. J. Infect. Dis. 197:1119-1123.
32. Bigey P, Gnidehou S, Doritchamou J, Quiviger M, Viwami F, Couturier A, Salanti A, Nielsen MA, Scherman D, Deloron P, Tuikue NN. 2011. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A. J. Infect. Dis. 204:1125-1133.
33. Tsai CW, Duggan PF, Jin AJ, Macdonald NJ, Kotova S, Lebowitz J, Hurt DE, Shimp RL, Jr., Lambert L, Miller LH, Long CA, Saul A, Narum DL. 2009. Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a nonlinear, multi-domain structure. Mol. Biochem. Parasitol. 164:45-56.
34. Elliott SR, Payne PD, Duffy MF, Byrne TJ, Tham WH, Rogerson SJ, Brown GV, Eisen DP. 2007. Antibody recognition of heterologous variant surface antigens after a single Plasmodium falciparum infection in previously naive adults. Am. J. Trop. Med. Hyg. 76. 5:860-864.
35. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S. 1999. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans. R. Soc. Trop. Med. Hyg. 93:369-374.
36. Avril M, Cartwright MM, Hathaway MJ, Smith JD. 2011. Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins. Malar J. 10:36. doi:10.1186/1475 -2875-10-36.
37. Bir N, Yazdani SS, Avril M, Layez C, Gysin J, Chitnis CE. 2006. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria. Infect. Immun. 74:5955-5963.
38. Cot M, Le Hesran JY, Staalsoe T, Fievet N, Hviid L, Deloron P. 2003. Maternally transmitted antibodies to pregnancy-associated variant antigens on the surface of erythrocytes infected with Plasmodium falciparum: relation to child susceptibility to malaria. Am. J. Epidemiol. 157:203-209.
39. Singh K, Gitti RK, Diouf A, Zhou H, Gowda DC, Miura K, Ostazeski SA, Fairhurst RM, Garboczi DN, Long CA. 2010. Subdomain 3 of Plasmodium falciparum VAR2CSA DBL3X is identified as a minimal chondroitin sulfate A binding region. J. Biol. Chem. 285:24855-24862.
40. Resende M, Ditlev SB, Nielsen MA, Bodevin S, Bruun S, Pinto VV, Clausen H, Turner L, Theander TG, Salanti A, Dahlback M. 2009. Chondroitin sulphate A (CSA)-binding of single recombinant Duffybinding-like domains is not restricted to Plasmodium falciparum erythrocyte membrane protein 1 expressed by CSA-binding parasites. Int. J. Parasitol. 39:1195-1204.
41. Oleinikov AV, Rossnagle E, Francis S, Mutabingwa TK, Fried M, Duffy PE. 2007. Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens. J. Infect. Dis. 196:155-164.
42. Tuikue Ndam NG, Salanti A, Le-Hesran JY, Cottrell G, Fievet N, Turner L, Sow S, Dangou JM, Theander T, Deloron P. 2006. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of Senegalese pregnant women. J. Infect. Dis. 193:713-720.
43. Tutterrow YL, Avril M, Singh K, Long CA, Leke RJ, Sama G, Salanti A, Smith JD, Leke RGF, Taylor DW. 2012. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Infect. Immun. 80:1479-1490.